ClinicalTrials.gg
Drug

Telavancin clinical trials

Also written VIBATIV and TD-6424.

studies test it
15
open now
1
in phase 3
5
first study started
2003

How each study uses telavancin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the telavancin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Sept 2009 · VIBATIV · NDA 022110 (FDA, Drugs@FDA)
European Union
2 Sept 2011 · Vibativ · EMEA/H/C/001240 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Telavancin
13
Telavancin Injection
2

Brand

VIBATIV
14

Development codes

TD-6424
9
ASP9809
1

Studies by the year they started

15 studies that test it; most in 2005 (4)

Studies that test telavancin, by start year
YearStudies
20032
20041
20054
20101
20111
20142
20151
20161
20171
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
4
Phase 3
5
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 5

Cumberland Pharmaceuticals (10) · M.D. Anderson Cancer Center (1) · Joseph L. Kuti, PharmD (1) · University of Michigan (1) · University of Illinois at Chicago (1) · Aaron Cook (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test telavancin.

Studies

Open first, then newest update. How each study uses telavancin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Codes

What other systems call telavancin · ClinicalTrials.gg INT004664

  • MeSH (NLM) C487637telavancinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) XK134822Z0TELAVANCINConfirmed FDA, NLM, Wikidata
  • RxNorm 473837Confirmed FDA, Wikidata
  • Wikidata Q7695658telavancinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87603TelavancinOne source FDA
  • DrugBank DB06402One source Wikidata

Also registered as telavancin hydrochloride (UNII 0701472ZG0 · RxNorm 864624).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.